No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
161 |
4. Check minimum number of eventsNone |
161 |
5. Include endpointsNone |
161 |
6. Filter based on genotype QC (FinnGen only) |
152 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80
- Name in latin
- Deficientia selectiva immunoglobulini A
Similar endpoints
↥List of similar endpoints to
Selective deficiency of immunoglobulin A [IgA]y
based on the number of shared cases.
Similar with more cases:
- Immunodeficiency with predominantly antibody defects
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1030 | 548 | 479 |
| Only index persons | 873 | 467 | 406 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 23.14 | 26.92 | 18.74 |
| Only index persons | 27.90 | 32.01 | 23.16 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 152 | 94 | 58 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 38.91 | 37.24 | 41.62 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 161
- Matched controls
- 1610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
190.9
143
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
33.5
31
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
24.6
23
*
2790B
ICD-9 Finland
Disorders involving the immune mechanism, Deficiency of humoral immunity[DEFICIENTIA IMMUNOGLOBULINI A]
+∞
24.6
23
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
24.6
23
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.2
23.8
103
408
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
23.5
22
*
J01MA14
ATC
moxifloxacin; systemic
7.1
22.4
39
69
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.5
21.6
28
35
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
21.3
20
*
ZX120
NOMESCO Finland
Intravenous
6.3
21.1
42
85
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.9
20.3
61
177
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
18.9
20.3
31
20
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
6.4
18.5
35
67
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.3
18.2
70
243
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
16.7
44
113
TPH04
NOMESCO Finland
Cathetrisation of vein
4.3
16.6
59
192
J01MA12
ATC
levofloxacin; systemic
4.7
16.1
47
131
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
15.9
15
*
H02AB06
ATC
prednisolone; systemic
3.9
15.6
103
506
H02AB07
ATC
prednisone; oral
4.8
14.4
38
97
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
6.9
13.8
23
38
Z3231
NOMESCO Finland
Registered nurse
3.5
13.2
73
312
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.7
12.1
48
165
6BA02, ,
NOMESCO Finland
70.2
11.8
13
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.6
11.6
24
49
R03DC03
ATC
montelukast; oral
3.7
11.6
47
163
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.9
11.4
22
42
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
11.0
74
348
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.1
10.9
34
98
J47
ICD-10 Finland
Bronchiectasis
17.6
10.6
16
10
J45.9
ICD-10 Finland
Asthma, unspecified
3.4
10.4
48
180
R50.9
ICD-10 Finland
Fever, unspecified
3.5
10.1
42
147
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
5.3
10.1
22
47
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
5.5
10.1
21
43
K90.0
ICD-10 Finland
Coeliac disease
10.6
10.1
19
20
SPAT1262
SPAT
Handing over of treatment supplies
3.7
9.9
36
115
J01FA15
ATC
telithromycin; oral
4.2
9.7
28
76
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
13.5
9.6
16
13
WX892
NOMESCO Finland
Monitored bed care
4.9
9.4
22
50
P01BA02
ATC
hydroxychloroquine; oral
4.4
9.4
26
68
J01MA02
ATC
ciprofloxacin; systemic
2.8
9.3
72
360
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.9
9.2
30
89
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.8
9.2
19
24
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.4
9.1
25
65
M05BA04
ATC
alendronic acid; oral
7.4
9.0
21
32
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.4
8.8
24
62
Z3229
NOMESCO Finland
Other healthcare associate professional
4.6
8.8
22
53
J01FA06
ATC
roxithromycin; oral
2.7
8.7
79
425
J01FA01
ATC
erythromycin; systemic
3.3
8.3
37
134
Z01.8
ICD-10 Finland
Other specified special examinations
3.0
8.3
47
196
L01BA01
ATC
methotrexate; systemic
9.7
8.3
16
18
J01FF01
ATC
clindamycin; systemic
2.8
8.2
57
266
C03CA01
ATC
furosemide; systemic
3.1
8.2
41
160
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
8.1
57
267
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.7
8.1
64
319
J01DA06
ATC
[U] cefuroxime
3.2
8.0
37
137
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.9
7.9
25
72
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
47.3
7.8
9
*
R05
ICD-10 Finland
Cough
2.9
7.7
45
191
WX002
NOMESCO Finland
Sedation and analgesia
3.1
7.6
37
141
L04AX03
ATC
methotrexate; systemic
3.7
7.6
26
79
Z2221
NOMESCO Finland
Medical doctor
2.6
7.5
63
321
A02BC02
ATC
pantoprazole; systemic
2.6
7.5
111
738
J01FA09
ATC
clarithromycin; systemic
2.5
7.4
68
361
L04AX01
ATC
azathioprine; systemic
4.9
7.4
17
38
R01AD05
ATC
budesonide; nasal
4.2
7.4
21
56
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
7.3
7
*
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
+∞
7.3
7
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.7
7.3
25
76
R03BA02
ATC
budesonide; inhalant
2.9
7.2
42
177
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.4
7.2
28
93
L04AA13
ATC
[U] leflunomide
10.8
7.2
13
13
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
8.1
7.1
15
20
Z3226
NOMESCO Finland
Physiotherapist
2.8
7.0
43
186
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
7.0
108
721
R01AD12
ATC
fluticasone furoate; nasal
2.4
6.9
70
387
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.4
6.9
27
90
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
6.8
22
64
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.0
6.7
20
55
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
6.7
67
367
WW200
NOMESCO Finland
Immunization
9.3
6.7
13
15
R03BA05
ATC
fluticasone; inhalant
2.7
6.7
46
211
GD1AD
NOMESCO Finland
Thorax CT examination
6.7
6.7
16
26
R03AC02
ATC
salbutamol; inhalant
2.4
6.6
107
722
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.4
6.5
109
744
L04AC07
ATC
tocilizumab; parenteral
72.6
6.5
7
*
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
11.7
6.4
11
10
L88
ICPC
Rheumatoid/seropositive arthritis
6.8
6.3
15
24
ZXA00
NOMESCO Finland
Right side
2.6
6.3
44
203
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
27.9
6.3
8
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
6.3
6
*
J06BA02
ATC
immunoglobulins, normal human, for intravascular adm.; systemic
+∞
6.3
6
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.0
6.3
30
113
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.7
6.2
40
177
UJF30
NOMESCO Finland
Ileoscopy through colon
3.5
6.2
23
74
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.5
6.1
22
69
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.0
6.1
18
49
H04.10
ICD-10 Finland
Dry eye syndrome
3.2
6.0
26
92
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
41
73
7.19
23.48
1.9
1.1
100.47
—
u/ml
—
12
0
47
98
6.36
23.01
1.6
1.2
154.39
352.63
u/ml
0.36
38
91
25
7
41.87
20.52
1.8
1.1
—
—
—
0
0
24
6
46.53
20.14
1.8
1.2
13.83
8.83
%
—
24
6
21
5
47.95
17.76
3.4
1.4
568.43
1023.00
u/ml
—
21
5
136
785
5.72
16.97
15.6
10.3
3.95
3.95
e9/l
0.01
128
684
94
468
3.42
13.30
7.5
5.2
36.82
36.60
g/l
0.15
86
453
101
527
3.46
13.20
11.2
8.3
1.21
1.21
mmol/l
0.18
87
461
99
520
3.35
12.61
3.5
2.4
75.52
74.50
nmol/l
0.15
93
469
15
5
32.81
11.87
2.1
1.2
24.53
26.60
%
—
15
5
14
5
30.42
10.92
1.0
1.0
94.00
81.60
%
—
14
5
28
71
4.56
10.55
2.8
1.6
—
—
—
0
0
47
173
3.42
10.51
2.3
1.7
—
—
—
0
0
81
437
2.72
8.89
5.5
2.9
—
—
—
0
0
39
143
3.28
8.64
11.8
7.7
1.09
1.10
mmol/l
0.11
39
133
68
355
2.58
7.75
5.5
2.6
0.17
0.38
e6/l
1.16
52
264
69
388
2.36
6.45
2.9
3.2
2.35
2.35
mmol/l
0.14
62
345
43
199
2.58
6.09
2.6
2.5
2.81
2.39
e6/l
0.11
19
100
30
116
2.95
5.97
2.5
1.5
—
—
—
0
0
43
207
2.47
5.57
2.6
2.3
0.71
0.89
e6/l
0.26
19
108
16
34
5.11
5.47
1.3
1.3
—
—
—
0
0
29
116
2.83
5.41
2.6
1.5
—
—
—
0
0
23
82
3.11
5.24
5.5
4.5
1.01
1.23
mmol/l
0.08
17
62
35
158
2.55
5.16
2.0
1.6
1152.07
1172.10
nmol/l
0.04
30
119
15
32
5.06
5.14
2.2
3.8
—
—
—
0
0
23
85
2.99
4.93
7.6
8.3
22.67
25.84
mmol/l
5.82
23
85
73
458
2.09
4.91
10.2
10.9
1.01
1.17
inr
3.75
21
149
8
7
11.94
4.84
1.3
1.4
—
—
—
0
0
13
26
5.34
4.75
2.4
4.5
0.00
0.00
g/l
-0.00
13
26
68
420
2.07
4.73
2.3
1.8
89.94
96.72
pmol/l
0.60
39
211
52
293
2.14
4.58
2.0
2.1
1.30
0.83
mg/l
0.87
41
222
11
19
6.13
4.53
2.1
1.2
—
—
—
0
0
12
24
5.31
4.41
1.3
1.9
—
—
—
0
0
13
29
4.78
4.35
1.5
1.9
—
—
—
0
0
91
638
1.98
4.33
6.2
3.1
0.05
0.01
estimate
0.39
22
148
46
252
2.16
4.32
1.8
1.4
20.65
22.72
nmol/l
0.37
38
217
17
57
3.22
4.27
2.4
1.5
—
—
—
0
0
13
30
4.62
4.23
1.5
1.9
—
—
—
0
0
14
42
3.56
4.15
1.4
1.3
—
—
—
0
0
13
31
4.47
4.12
1.7
1.3
—
—
—
0
0
13
31
4.47
4.12
1.7
1.3
—
—
—
0
0
8
10
8.35
4.11
4.5
3.0
—
—
—
0
0
12
27
4.71
4.02
1.4
1.4
387.43
327.48
ug/g
—
7
13
15
50
3.21
3.80
1.2
1.3
—
—
—
0
0
12
29
4.38
3.79
2.0
1.2
—
—
—
0
0
11
25
4.64
3.70
1.9
3.0
—
—
—
0
0
89
642
1.86
3.67
7.9
4.4
0.00
0.00
estimate
-0.00
21
140
61
392
1.90
3.60
5.0
3.3
283.45
37.83
ng/l
0.60
31
223
89
646
1.84
3.56
6.3
3.2
0.00
0.02
estimate
0.50
20
134
25
115
2.39
3.51
6.7
7.0
0.41
2.14
mmol/l
1.00
18
89
143
1223
2.51
3.51
21.5
10.6
89.67
89.17
ml/min/173m2
0.08
129
979
15
53
3.02
3.46
1.1
1.1
—
—
—
0
0
9
18
5.23
3.42
1.6
1.8
—
—
—
0
0
9
18
5.23
3.42
1.6
1.8
—
—
—
0
0
15
54
2.96
3.36
2.0
1.4
—
—
—
0
0
52
326
1.88
3.26
7.2
3.5
0.00
0.01
estimate
0.50
20
140
8
15
5.55
3.23
2.5
1.7
—
—
—
0
0
7
11
6.59
3.22
4.1
2.2
—
—
—
0
0
10
25
4.19
3.14
2.6
4.5
0.00
0.00
g/l
—
10
25
10
25
4.19
3.14
2.6
4.5
0.00
0.00
g/l
—
10
25
8
16
5.20
3.09
2.5
1.7
—
—
—
0
0
8
16
5.20
3.09
2.5
1.7
—
—
—
0
0
8
16
5.20
3.09
2.5
1.7
—
—
—
0
0
8
16
5.20
3.09
2.5
1.7
—
—
—
0
0
8
16
5.20
3.09
2.5
1.7
—
—
—
0
0
124
1023
1.92
3.06
5.4
3.8
14.71
14.52
pmol/l
0.39
117
941
10
26
4.03
3.03
1.9
2.2
—
—
—
0
0
39
227
1.95
3.03
1.3
1.3
10.43
26.24
iu/ml
—
9
76
11
32
3.61
2.96
6.3
4.5
61.45
55.09
%
0.75
11
32
11
32
3.61
2.96
6.2
3.8
4.97
3.90
e9/l
0.69
11
32
8
17
4.89
2.96
1.4
1.2
—
—
—
0
0
10
27
3.88
2.93
1.2
1.2
—
1.01
—
0
12
7
13
5.57
2.90
4.1
2.0
—
—
—
0
0
15
59
2.70
2.88
1.7
1.3
—
—
—
0
0
9
23
4.08
2.82
2.6
1.5
—
—
—
0
0
5
6
8.55
2.77
1.4
2.2
—
—
—
0
0
5
6
8.55
2.77
1.4
2.2
—
—
—
0
0
5
6
8.55
2.77
1.4
2.2
—
—
—
0
0
44
277
1.81
2.67
2.9
2.2
—
—
—
0
0
7
15
4.83
2.62
1.3
1.9
—
—
—
0
0
68
487
1.69
2.62
6.9
3.2
—
—
—
0
0
14
56
2.64
2.61
1.1
1.3
—
—
—
0
0
8
20
4.15
2.60
1.5
1.5
—
—
—
0
0
13
50
2.74
2.60
2.3
3.3
—
—
—
0
0
24
124
2.10
2.57
3.0
1.8
—
—
—
0
0
7
16
4.52
2.50
1.3
1.3
—
—
—
0
0
10
32
3.26
2.48
3.2
1.5
—
—
—
0
0
21
105
2.15
2.44
5.1
3.1
—
—
—
0
0
45
293
1.74
2.42
3.7
3.0
363.93
8393.70
umol/l
1.72
40
269
12
46
2.74
2.42
1.7
2.0
—
—
—
0
0
38
236
1.80
2.40
1.3
1.3
1.56
5.85
u/ml
1.04
20
99
8
22
3.77
2.40
1.4
2.0
—
—
—
0
0
5
8
6.40
2.39
1.4
2.0
—
—
—
0
0
5
8
6.40
2.39
1.4
2.0
—
—
—
0
0
7
17
4.25
2.38
1.3
1.8
—
—
—
0
0
12
47
2.68
2.33
2.3
4.2
92.00
96.66
%
0.42
12
47
6
13
4.75
2.29
1.7
1.2
—
—
—
0
0
6
13
4.75
2.29
2.8
1.0
—
—
—
0
0
7
18
4.02
2.28
1.1
2.1
—
—
—
0
0
5
9
5.69
2.23
1.4
1.9
—
—
—
0
0
30
177
1.85
2.22
2.8
3.0
2.44
2.44
mmol/l
0.13
24
161
27
155
1.89
2.17
3.0
1.9
—
—
—
0
0
6
14
4.41
2.17
2.8
1.1
—
—
—
0
0
5
10
5.12
2.08
1.0
1.2
—
—
—
0
0
11
45
2.55
1.97
2.9
1.8
—
—
—
0
0
5
11
4.65
1.95
1.4
2.0
—
—
—
0
0
5
11
4.65
1.95
1.4
2.0
—
—
—
0
0
5
11
4.65
1.95
1.4
2.0
—
—
—
0
0
52
373
1.58
1.89
1.9
1.8
—
—
—
0
0
5
13
3.93
1.73
1.0
1.2
—
—
—
0
0
12
56
2.23
1.65
1.7
1.6
—
—
—
0
0
122
1076
1.55
1.58
4.9
3.7
—
—
—
0
0
5
15
3.40
1.53
1.4
2.2
—
—
—
0
0
6
21
2.93
1.52
2.0
1.8
—
—
—
0
0
74
595
1.45
1.51
3.2
2.5
—
—
—
0
0
47
346
1.51
1.49
1.4
1.7
1.53
1.37
mmol/l
0.43
38
296
42
304
1.52
1.44
6.5
3.6
27.49
10.79
mg/mmol
0.35
30
192
21
129
1.72
1.38
7.9
8.6
105.76
104.17
mmol/l
1.04
21
129
5
19
2.68
1.22
1.4
2.1
—
—
—
0
0
9
165
0.52
1.16
1.2
1.7
—
—
—
0
0
11
58
1.96
1.15
8.9
10.3
92.57
94.15
%
0.29
11
58
10
51
2.02
1.14
13.7
4.7
56.86
55.87
%
—
10
51
5
22
2.31
1.04
1.0
1.0
—
—
—
0
0
9
48
1.93
1.02
1.2
1.1
—
—
—
0
0
0
30
0.00
0.98
0.0
1.4
—
—
—
0
0
11
62
1.83
0.97
6.9
7.4
118.00
129.24
g/l
0.69
11
62
10
55
1.87
0.94
2.4
6.5
0.69
0.68
%
—
10
55
10
56
1.84
0.90
2.5
6.4
1.94
1.58
%
—
10
56
6
31
1.97
0.85
1.0
1.1
—
—
—
0
0
8
46
1.78
0.84
1.3
1.1
—
—
—
0
0
12
74
1.67
0.80
1.9
1.6
276.67
317.45
mu/l
0.40
12
64
27
203
1.40
0.77
4.0
3.4
229.35
220.85
ng/l
0.01
17
130
34
275
1.30
0.62
3.5
3.9
1.26
1.68
ug/l
1.29
34
250
0
20
0.00
0.61
0.0
1.0
—
—
—
0
0
138
1317
1.33
0.59
5.0
4.1
2.70
2.85
mmol/l
1.10
132
1238
13
95
1.40
0.45
1.0
1.0
—
—
—
0
0
5
33
1.53
0.41
3.2
4.3
23.00
24.77
mmol/l
—
5
33
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
12
89
1.38
0.39
1.2
1.3
—
—
—
0
0
9
69
1.32
0.38
1.4
1.7
—
—
—
0
0
14
108
1.32
0.36
1.4
1.2
36.00
118.82
iu/ml
—
7
40
103
984
1.13
0.27
4.5
3.2
45.31
40.78
u/l
0.22
98
945
134
1303
1.17
0.26
4.8
3.8
1.43
1.45
mmol/l
0.21
128
1221
25
220
1.16
0.23
3.5
3.9
25.24
22.88
%
—
9
85
19
164
1.18
0.21
2.7
2.7
0.64
0.72
ug/l
0.25
12
97
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.6
—
51.64
—
0
11
6
48
1.26
0.20
16.2
5.3
22.85
24.45
mmol/l
—
6
48
0
14
0.00
0.20
0.0
1.2
—
208.06
—
0
14
7
60
1.17
0.18
1.0
1.3
—
—
—
0
0
127
1241
1.11
0.17
4.7
3.7
5.89
5.76
mmol/l
0.51
120
1157
11
130
0.83
0.16
1.2
1.5
—
—
—
0
0
29
269
1.10
0.12
3.0
2.2
—
—
—
0
0
5
45
1.11
0.10
4.0
2.3
6.98
4.85
umol/l
—
5
34
5
47
1.07
0.09
1.2
1.4
—
—
—
0
0
112
1140
0.94
0.09
7.3
4.7
39.39
38.66
mmol/mol
0.28
107
1083
5
61
0.81
0.08
1.4
1.4
—
—
—
0
0
13
117
1.12
0.08
11.3
6.4
—
—
—
0
0
26
247
1.06
0.06
3.1
2.0
—
—
—
0
0
126
1246
1.05
0.06
4.5
3.5
1.31
1.28
mmol/l
0.18
120
1163
26
258
1.01
0.00
2.0
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.2
—
213.83
—
0
6
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_DEF_IIGA and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have D3_DEF_IIGA.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: D3_DEF_IIGA – Selective deficiency of immunoglobulin A [IgA]y
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data